TAXUS Libertē Post Approval Study
NCT00997503 is an observational study sponsored by Boston Scientific Corporation. As of 21 Nov 2026, it is completed. It studies Aspirin, Placebo and Prasugrel in Coronary Artery Disease. The registry lists an enrollment of 4,199 participants at 82 sites in 1 country. The registry lists a start date of 31 Dec 2009 and a primary completion date of 31 Mar 2013.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT00997503 |
| Status | Completed |
| Study type | Observational study |
| Lead sponsor | Boston Scientific Corporation |
| Enrollment | 4,199 |
| Registered sites | 82 |
| Countries | 1 |
| Conditions | Coronary Artery Disease |
| Drugs | Aspirin, Placebo and Prasugrel |
| Start | 31 Dec 2009 |
| Primary completion | 31 Mar 2013 |
| Study completion | 31 Jul 2015 |
| Last update posted | 7 Aug 2015 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- David P Lee, MD
Stanford University
Principal Investigator - Kirk N Garratt, MD
Lenox Hill Hospital
Principal Investigator - Peter M Maurer, MPH
Boston Scientific Corporation
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
82 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Advanced Cardiac Specialists
Mesa
- Nea Baptist Memorial Hospital
Jonesboro
- St. Bernard's Medical Center
Jonesboro
- Baptist Health Medical Center
Little Rock
- Bakersfield Heart
Bakersfield
- Bakersfield Memorial Hospital
Bakersfield
- Mercy General Hospital
Sacramento
- Alvarado Hospital
San Diego
- Stanford University Medical Center
Stanford
- Torrance Memorial Medical Center
Torrance
- St. Anthony Central Hospital
Denver
- Medical Center of the Rockies (loveland)
Loveland
- St. Vincent's Medical Center
Bridgeport
- Christiana Hospital
Newark
- Jfk Medical Center
Atlantis
- North Florida Regional Medical Center
Gainesville
- Baptist Medical Center
Jacksonville
- Memorial Hospital Jacksonville/ Orange Park Medical Center
Jacksonville
- Holmes Regional Medical Center
Melbourne
- Florida Hospital
Orlando
- Baptist Hospital
Pensacola
- Sacred Heart Hospital
Pensacola
- Bayfront Medical Center
St. Petersburg
- Martin Memorial Medical Center
Stuart
- University Community Hospital
Tampa
- Kaiser Foundation Hospitals
Honolulu
- Kootenai Medical Center
Coeur d'Alene
- Macneal Hospital
Berwyn
- Jesse Brown Va Medical Center
Chicago
- Iu Health North Medical Center
Carmel
- Indiana Heart Hospital
Indianapolis
- King's Daughters Medical Center- Kentucky Heart Institute
Ashland
- St. Joseph Hospital
Lexington
- Christus St. Frances Cabrini Hospital
Alexandria
- Cardiovascular Research, Llc
Shreveport
- Eastern Maine Medical Center
Bangor
- Central Maine Medical Center
Lewiston
- Genesys Regional Medical Center
Grand Blanc
- Ingham Regional Medical Center
Lansing
- Mid Michigan Medical Center
Midland
- St. Mary's Medical Center
Mount Pleasant
- Northern Michigan Hospital
Petoskey
- Covenant Medical Center
Saginaw
- Lakeland Hospital at St. Joseph
Saint Joseph
- Providence Hospital
Southfield
- North Memorial Medical Center
Minneapolis
- United Heart and Vascular Clinic
Saint Paul
- Memorial Hospital at Gulfport
Gulfport
- North Mississippi Medical Center
Tupelo
- Freeman West Hospital
Joplin
- Cox Medical Centers
Springfield
- St. John's Mercy Medical Center
St Louis
- Our Lady of Lourdes Medical Center
Camden
- Hackensack University Medical Center
Hackensack
- Jersey Shore University Medical Center
Neptune City
- Heart Hospital of New Mexico
Albuquerque
- Maimonides Medical Center
Brooklyn
- Columbia University/ New York Presbyterian Hospital
New York
- Lenox Hill Hospital
New York
- St. Elizabeth Medical Center
Utica
- Gaston Memorial Hospital
Gastonia
- Wake Medical Center
Raleigh
- Ohio State University Medical Center
Columbus
- Med Central Health System- Mid Ohio Heart Clinic
Mansfield
- St. Vincent Mercy Medical Center
Toledo
- Oklahoma Heart Hospital
Oklahoma City
- University of Oklahoma Health Science Center
Oklahoma City
- Conemaugh Valley Memorial Hospital
Johnstown
- Presbyterian University of Pennsylvania Medical Center
Philadelphia
- Palmetto Richland Memorial Hospital
Columbia
- Sisters of Charity Providence Hospital
Columbia
- Grand Strand Regional Medical Center
Myrtle Beach
- Rapid City Regional Hospital
Rapid City
- Avera Heart Hospital of South Dakota
Sioux Falls
- Jackson Madison County General Hospital
Jackson
- Baylor Jack and Jane Hamilton Heart and Vascular Hospital
Dallas
- Doctors Hospital at Renaissance/ Mcallen Heart Hospital
Edinburg
- Michael E. Debakey Va Medical Center
Houston
- Kingwood Medical Center
Kingwood
- Methodist Texsan Hospital
San Antonio
- Cardiovascular Associates of East Texas Medical Center
Tyler
- Meriter Hospital, Inc.
Madison
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Questions about NCT00997503
Each answer restates registry values shown on this page.
What is NCT00997503?
NCT00997503 is an observational study sponsored by Boston Scientific Corporation. It studies Aspirin, Placebo and Prasugrel in Coronary Artery Disease.
Who leads NCT00997503?
The registry names David P Lee, MD (principal investigator, Stanford University), Kirk N Garratt, MD (principal investigator, Lenox Hill Hospital) and Peter M Maurer, MPH (study director, Boston Scientific Corporation) as overall officials.
Where does NCT00997503 run?
The registry lists 82 sites in 1 country. Every site with a stated country is in one country: United States.
Which drugs does NCT00997503 study?
The registered drug and biological interventions are Aspirin, Placebo and Prasugrel.
When did NCT00997503 end?
The registry lists a primary completion date of 31 Mar 2013 and a study completion date of 31 Jul 2015. The sponsor last updated the record on 7 Aug 2015.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.